Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Almirall, S.a.

Clinical trials sponsored by Almirall, S.a., explained in plain language.

Almirall, S.A. ALM BME

A pharmaceutical company focused on dermatology and medical aesthetics.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 3 Not yet recruiting 2 Not yet finished but already full! 1 Completed 7

Eczema drug trial could mean fewer shots for patients

Disease control Ongoing

This study tests the drug lebrikizumab in 520 adults and teens (ages 12+) with moderate-to-severe eczema. Part 1 looks at how well the drug improves skin symptoms over 24 weeks. Part 2 compares a new dosing schedule (every 12 weeks) to the current one (every 4 weeks) to see if it…

Phase: PHASE3 • Sponsor: Almirall, S.A. • Aim: Disease control

Last updated Jun 27, 2026 12:23 UTC